You are here

Article metrics

Article menu

Download PDFPDF

XML
Hepatology
Original article
Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal

 

Online download statistics by month:

Online download statistics by month: January 2017 to February 2023

AbstractFullPdf
Jan 2017676359277
Feb 201785224197
Mar 20170236134
Apr 20173313154
May 20172281118
Jun 201761252120
Jul 2017247247129
Aug 2017727725270
Sep 2017373374158
Oct 2017280280109
Nov 2017295296122
Dec 201722923292
Jan 2018277277109
Feb 201824424186
Mar 201824725077
Apr 201826926870
May 201833634182
Jun 201816316567
Jul 201821521368
Aug 201824023475
Sep 201818018067
Oct 201827126585
Nov 201823023067
Dec 201820520560
Jan 201919118889
Feb 201918418186
Mar 2019188185118
Apr 2019157150113
May 201915815875
Jun 201912712757
Jul 201911310958
Aug 201912511273
Sep 2019978555
Oct 2019898345
Nov 201912110761
Dec 2019847753
Jan 20201138665
Feb 2020826245
Mar 2020948463
Apr 2020787065
May 2020997758
Jun 2020847269
Jul 20201067474
Aug 2020745649
Sep 2020988065
Oct 20201078840
Nov 2020827466
Dec 2020938077
Jan 2021997948
Feb 2021947655
Mar 20211108676
Apr 2021968064
May 20211159569
Jun 2021969784
Jul 202110510979
Aug 2021818154
Sep 202110510576
Oct 202113411879
Nov 202113110491
Dec 202111310446
Jan 202212311355
Feb 2022938642
Mar 20221119149
Apr 20221279551
May 2022887433
Jun 202211913869
Jul 2022897736
Aug 2022827724
Sep 2022969341
Oct 202212711066
Nov 2022968254
Dec 2022907935
Jan 202312910653
Feb 202313712753
Total11385116355894